Back to search
FDAFDA · Food and drugs·Recall number D-0244-2026

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Published January 7, 2026 · Recall initiated: December 19, 2025

Summary

FDA records drug Class II recall D-0244-2026, published January 7, 2026 and initiated December 19, 2025. Recalling firm: Novo Nordisk Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Hair was found in a prefilled syringe

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novo Nordisk Inc.
Distributor
Nationwide within the United States.
Lot
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14 recalled?

Yes. FDA published recall D-0244-2026 on January 7, 2026. Reported hazard: Presence of Particulate Matter: Hair was found in a prefilled syringe

What should I do if I have this product?

Voluntary: Firm initiated · Letter